161 related articles for article (PubMed ID: 33045891)
21. Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway.
Zhang B; Zhang J; Ainiwaer Y; He B; Geng Q; Lin L; Li X
Ann Clin Lab Sci; 2021 May; 51(3):376-384. PubMed ID: 34162568
[TBL] [Abstract][Full Text] [Related]
22. Lidocaine relieves spinal cord ischemia-reperfusion injury via long non-coding RNA MIAT-mediated Notch1 downregulation.
Hou J; Li H; Xue C; Ma J
J Biochem; 2022 Mar; 171(4):411-420. PubMed ID: 34981118
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction.
Qi X; Shao M; Sun H; Shen Y; Meng D; Huo W
Neuroscience; 2017 Apr; 348():98-106. PubMed ID: 28215748
[TBL] [Abstract][Full Text] [Related]
24. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
25. Dexmedetomidine Preconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Necroptosis by Inhibiting HMGB1-Mediated Inflammation.
Chen J; Jiang Z; Zhou X; Sun X; Cao J; Liu Y; Wang X
Cardiovasc Drugs Ther; 2019 Feb; 33(1):45-54. PubMed ID: 30675709
[TBL] [Abstract][Full Text] [Related]
26. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Bell MT; Agoston VA; Freeman KA; Puskas F; Herson PS; Mares J; Fullerton DA; Reece TB
J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057
[TBL] [Abstract][Full Text] [Related]
27. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ
Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841
[TBL] [Abstract][Full Text] [Related]
28. Dexmedetomidine Attenuates Spinal Cord Ischemia-reperfusion Injury in Rabbits by Decreasing Oxidation and Apoptosis.
Liu B; Liang Y; Huang W; Zhang H; Zhou D; Xiao X
Curr Mol Med; 2023; 23(6):569-577. PubMed ID: 35619277
[TBL] [Abstract][Full Text] [Related]
29. Dexmedetomidine attenuates the neuroinflammation and cognitive dysfunction in aged mice by targeting the SNHG14/miR‑340/NF‑κB axis.
He G; Ni H; Wang K; Gao H; Li Y; Gu J; Ni X; Wang Z; Bao Y
Biomed Rep; 2023 Dec; 19(6):100. PubMed ID: 37954634
[TBL] [Abstract][Full Text] [Related]
30. Cooling and Sterile Inflammation in an Oxygen-Glucose-Deprivation/Reperfusion Injury Model in BV-2 Microglia.
Lücht J; Rolfs N; Wowro SJ; Berger F; Schmitt KRL; Tong G
Mediators Inflamm; 2021; 2021():8906561. PubMed ID: 34776788
[TBL] [Abstract][Full Text] [Related]
31. Effects of Dexmedetomidine and Oxycodone on Neurocognitive and Inflammatory Response After Tourniquet-Induced Ischemia-Reperfusion Injury.
Zhao S; Cheng WJ; Liu X; Li Z; Li HZ; Shi N; Wang XL
Neurochem Res; 2022 Feb; 47(2):461-469. PubMed ID: 34625874
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
33. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
34. Silence of Long Noncoding RNA SNHG14 Alleviates Ischemia/Reperfusion-Induced Acute Kidney Injury by Regulating miR-124-3p/MMP2 Axis.
Xue Q; Yang L; Wang H; Han S
Biomed Res Int; 2021; 2021():8884438. PubMed ID: 33490282
[TBL] [Abstract][Full Text] [Related]
35. Uric acid inhibits HMGB1-TLR4-NF-κB signaling to alleviate oxygen-glucose deprivation/reoxygenation injury of microglia.
Wang Q; Zhao H; Gao Y; Lu J; Xie D; Yu W; He F; Liu W; Hisatome I; Yamamoto T; Wang W; Cheng J
Biochem Biophys Res Commun; 2021 Feb; 540():22-28. PubMed ID: 33429196
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MEG3 regulates microglial polarization through KLF4 to affect cerebral ischemia-reperfusion injury.
Li T; Luo Y; Zhang P; Guo S; Sun H; Yan D; Liu X; Yang B
J Appl Physiol (1985); 2020 Dec; 129(6):1460-1467. PubMed ID: 33180644
[TBL] [Abstract][Full Text] [Related]
37. Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis.
Chen Y; Fan Z; Wu Q
Bioengineered; 2021 Dec; 12(1):4794-4804. PubMed ID: 34334080
[TBL] [Abstract][Full Text] [Related]
38. Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy.
Fu Z; Pang Z; He L; Zhang L; Fan Y; Zhao C; Yang J
Neurochem Res; 2022 Nov; 47(11):3490-3505. PubMed ID: 36042140
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
40. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
